Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03778489
Other study ID # PANX-HYP
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 19, 2019
Est. completion date November 1, 2022

Study information

Verified date November 2022
Source University of Copenhagen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Sympathetic nervous activity plays an important role in the development of hypertension and studies have shown that the pannexin-1 channel is involved in the signalling of the sympathetic activity to the vascular bed. The main project aim is to investigate the effects of 10 weeks of high intensity training on the effect of the sympathetic nervous activity on vascular function in individuals with essential hypertension. A secondary aim is to assess the role of essential hypertension and physical activity on vascular endothelial function,


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date November 1, 2022
Est. primary completion date November 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 35 Years to 65 Years
Eligibility Inclusion Criteria: - Sedentary men and women age 35 - 65 years - Resting blood pressure >140/90 mmHg or Resting blood pressure <140/90 mmHg - Essential hypertension - Non or exclusively antihypertensive medication Exclusion Criteria: - Hypertensive condition other than essential hypertension - Other chronical diseases - Smoking - Excess alcohol intake or drug abuse

Study Design


Intervention

Other:
Training
10 weeks of high intensity exercise training. 2-3 trainings per week of approx. 40 min.

Locations

Country Name City State
Denmark University of Copenhagen Copenhagen

Sponsors (3)

Lead Sponsor Collaborator
University of Copenhagen Danish Council for Independent Research, Lundbeck Foundation

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood pressure Changes in systolic and diastolic blood pressure Before and after 8 weeks of training
Secondary Pannexin channel function assessed in vivo Pannexin channel function is assessed by measurement of vascular conductance with and without channel inhibition Before and after 8 weeks of training
Secondary Pannexin channel distribution in skeletal muscle tissue Pannexin channel distribution is assessed immunohistochemically in muscle samples Before and after 8 weeks of training
Secondary Sympathetic activity Direct measurement of Muscle Sympathetic Nervous Activity via microneurography Before and after 8 weeks of training
Secondary Vascular function Vascular conductance measured by ultrasound doppler during infusion of vasoactive substances Before and after 8 weeks of training
Secondary Mitochondrial function in endothelial cells Endothelial cell mitochondrial respiration is measured by High Resolution Respirometry Before and after 8 weeks of training
Secondary Reactive oxygen species formation in in endothelial cells Endothelial cell production of reactive oxygen species is measured by High Resolution Respirometry Before and after 8 weeks of training
Secondary Rheology Platelet rheology. The viscoelastic measurements are based on attainment of the Gel Point (GP) from which the fractal dimension, df, is determined. Before and after 8 weeks of training
Secondary Platelet reactivity Platelet reactivity is assessed by multiplate aggregometry Before and after 8 weeks of training
Secondary Maximal oxygen uptake Direct Measurement of oxygen uptake during a graded test on cycle ergometer Before and after 8 weeks of training
Secondary Body Composition Measured by Dual energy x-ray absorptiometry Before and after 8 weeks of training
Secondary Endothelial cell characterization Assessment of protein and mRNA-levels of proteins of relevance for endothelial function Before and after 8 weeks of training
Secondary Skeletal muscle characterization Assessment of protein and mRNA-levels of proteins of relevance for skeletal muscle function Before and after 8 weeks of training
See also
  Status Clinical Trial Phase
Recruiting NCT05546931 - Mobile Health Program for Rural Hypertension N/A
Completed NCT05086549 - An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria
Recruiting NCT05086523 - Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study Phase 1/Phase 2
Active, not recruiting NCT03503773 - The TARGET BP OFF-MED Trial Phase 2
Not yet recruiting NCT04082091 - Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
Recruiting NCT06019598 - Licorice and Home Blood Pressure, Additional Study N/A
Completed NCT04495231 - Sympathetic Activity and Cardiometabolic Complications
Completed NCT04119999 - A Cardiosleep Research Program on Obstructive Sleep Apnea, Blood Pressure Control and Maladaptive Myocardial Remodeling N/A
Recruiting NCT04505618 - Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease N/A
Recruiting NCT04863508 - Wearable Blood Pressure Devices to Identify Masked Uncontrolled Hypertension.
Completed NCT05185297 - Recreational Futsal for Controlled Hypertension N/A
Completed NCT03855605 - Diagnosis of Hypertension by Home Blood Pressure Monitoring
Completed NCT03901183 - Plant-based Nutrition for Patients With Cardiovascular Risk Factors N/A
Recruiting NCT06348576 - Phase III Study to Evaluate the Efficacy and Safety of AD-209 Phase 3
Recruiting NCT03206814 - Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System N/A
Recruiting NCT06343246 - Functional Inspiratory Muscle Training in Patients Diagnosed With Hypertension N/A
Completed NCT06359873 - Left Atrial Enlargement: A Crucial Indicator for Identifying Atrial Fibrillation in Patients With Hypertension
Recruiting NCT04565548 - Hypertension Treatment Adherence Improving Trial N/A
Recruiting NCT06205628 - Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension Phase 1
Recruiting NCT04613193 - Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis N/A